{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:31:14Z","timestamp":1778891474575,"version":"3.51.4"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T00:00:00Z","timestamp":1637280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.vascn.2021.107133","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T03:43:00Z","timestamp":1637120580000},"page":"107133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Optimization of a histamine-induced allergic conjunctivitis model in Guinea pigs"],"prefix":"10.1016","volume":"113","author":[{"given":"Hidemi","family":"Mochizuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Suyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joo Young","family":"Cha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pil-Su","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihito","family":"Shimoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7485","key":"10.1016\/j.vascn.2021.107133_bb0005","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/505612a","article-title":"Policy: NIH plans to enhance reproducibility","volume":"505","author":"Collins","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.vascn.2021.107133_bb0010","series-title":"The Association of Food and Drug Officials of the United States","article-title":"Dermal toxicity. In: Appraisal of the safety of chemicals in foods, drugs and cosmetics","author":"Draize","year":"1959"},{"key":"10.1016\/j.vascn.2021.107133_bb0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13223-020-0403-9","article-title":"A contemporary look at allergic conjunctivitis","volume":"16","author":"Dupuis","year":"2020","journal-title":"Allergy, Asthma and Clinical Immunology"},{"issue":"3","key":"10.1016\/j.vascn.2021.107133_bb0020","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/all.13334","article-title":"Clinical implications of mast cell involvement in allergic conjunctivitis","volume":"73","author":"Elieh Ali Komi","year":"2018","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.vascn.2021.107133_bb0025","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/ICO.0b013e3181a18acd","article-title":"Image analyses of the kinetic changes of conjunctival hyperemia in histamine-induced conjunctivitis in Guinea pigs","volume":"28","author":"Fukushima","year":"2009","journal-title":"Cornea"},{"issue":"12","key":"10.1016\/j.vascn.2021.107133_bb0030","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1248\/bpb.26.1696","article-title":"Multiple cedar pollen challenge diminishes involvement of histamine in allergic conjunctivitis of Guinea pigs","volume":"26","author":"Fukushima","year":"2003","journal-title":"Biological & Pharmaceutical Bulletin"},{"issue":"1","key":"10.1016\/j.vascn.2021.107133_bb0035","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrneurol.2013.232","article-title":"Bringing rigour to translational medicine","volume":"10","author":"Howells","year":"2014","journal-title":"Nature Reviews. Neurology"},{"issue":"5","key":"10.1016\/j.vascn.2021.107133_bb0040","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/ACI.0000000000000205","article-title":"Environmental aeroallergens and allergic rhino-conjunctivitis","volume":"15","author":"Jalbert","year":"2015","journal-title":"Current Opinion in Allergy and Clinical Immunology"},{"issue":"8","key":"10.1016\/j.vascn.2021.107133_bb0045","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1248\/bpb1978.14.467","article-title":"Inhibitory effect of levocabastine on experimental allergic conjunctivitis in guinea pigs","volume":"14","author":"Kamei","year":"1991","journal-title":"Journal of Pharmacobio-Dynamics"},{"issue":"4","key":"10.1016\/j.vascn.2021.107133_bb0050","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1254\/jphs.FP0040265","article-title":"Apafant, a potent platelet-activating factor antagonist, blocks eosinophil activation and is effective in the chronic phase of experimental allergic conjunctivitis in guinea pigs","volume":"95","author":"Kato","year":"2004","journal-title":"Journal of Pharmacological Sciences"},{"issue":"1","key":"10.1016\/j.vascn.2021.107133_bb0055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1089\/jop.2015.0098","article-title":"An independent evaluation of a novel peptide mimetic, Brilacidin (PMX30063), for ocular anti-infective","volume":"32","author":"Kowalski","year":"2016","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"key":"10.1016\/j.vascn.2021.107133_bb0060","first-page":"245370","article-title":"Possible mechanism of action of the antiallergic effect of an aqueous extract of Heliotropium indicum L. in ovalbumin-induced allergic conjunctivitis","volume":"2015","author":"Kyei","year":"2015","journal-title":"Journal of Allergy (Cairo)"},{"issue":"1","key":"10.1016\/j.vascn.2021.107133_bb0065","doi-asserted-by":"crossref","first-page":"20477","DOI":"10.1038\/s41598-020-77511-2","article-title":"Naringin derivatives as glucosamine-6-phosphate synthase inhibitors based preservatives and their biological evaluation","volume":"10","author":"Lather","year":"2020","journal-title":"Scientific Reports"},{"key":"10.1016\/j.vascn.2021.107133_bb0070","series-title":"Dermatoxicology and pharmacology","article-title":"Eye irritation","author":"McDonald","year":"1977"},{"issue":"6","key":"10.1016\/j.vascn.2021.107133_bb0075","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000267046","article-title":"Effect of topical dexamethasone on the ocular allergic reaction in passively sensitized guinea pigs","volume":"22","author":"Mehta","year":"1990","journal-title":"Ophthalmic Research"},{"issue":"3","key":"10.1016\/j.vascn.2021.107133_bb0080","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.biocel.2007.08.011","article-title":"The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis?","volume":"40","author":"Moeller","year":"2008","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"issue":"1\u20133","key":"10.1016\/j.vascn.2021.107133_bb0085","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejphar.2009.02.035","article-title":"Role of histamine H(4) receptor in allergic conjunctivitis in mice","volume":"608","author":"Nakano","year":"2009","journal-title":"European Journal of Pharmacology"},{"issue":"6","key":"10.1016\/j.vascn.2021.107133_bb0090","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.2165\/00003495-199550060-00009","article-title":"Levocabastine. An update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis","volume":"50","author":"Noble","year":"1995","journal-title":"Drugs"},{"key":"10.1016\/j.vascn.2021.107133_bb0095","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-1-4419-8056-4_5","article-title":"The role of histamine in ocular allergy","volume":"709","author":"Ohbayashi","year":"2010","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"9","key":"10.1016\/j.vascn.2021.107133_bb0100","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/laban.1330","article-title":"Systematic heterogenization for better reproducibility in animal experimentation","volume":"46","author":"Richter","year":"2017","journal-title":"Laboratory Animals (NY)"},{"issue":"8","key":"10.1016\/j.vascn.2021.107133_bb0105","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1248\/bpb.33.1314","article-title":"Inhibitory effects of cyclosporine a eye drops on symptoms in late phase and delayed-type reactions in allergic conjunctivitis models","volume":"33","author":"Shii","year":"2010","journal-title":"Biological & Pharmaceutical Bulletin"},{"issue":"4","key":"10.1016\/j.vascn.2021.107133_bb0110","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1089\/jop.2009.0009","article-title":"Cyclosporine a eye drops inhibit the early-phase reaction in a type-I allergic conjunctivitis model in mice","volume":"25","author":"Shii","year":"2009","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"issue":"2","key":"10.1016\/j.vascn.2021.107133_bb0115","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/jop.1985.1.183","article-title":"Pharmacologic inhibition of immediate hypersensitivity in the guinea pig conjunctiva","volume":"1","author":"Stock","year":"1985","journal-title":"Journal of Ocular Pharmacology"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871921001866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871921001866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:04:47Z","timestamp":1761005087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871921001866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":23,"alternative-id":["S1056871921001866"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2021.107133","relation":{},"ISSN":["1056-8719"],"issn-type":[{"value":"1056-8719","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimization of a histamine-induced allergic conjunctivitis model in Guinea pigs","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2021.107133","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107133"}}